HK1173358A1 - 衍生肽 - Google Patents

衍生肽

Info

Publication number
HK1173358A1
HK1173358A1 HK12111247.4A HK12111247A HK1173358A1 HK 1173358 A1 HK1173358 A1 HK 1173358A1 HK 12111247 A HK12111247 A HK 12111247A HK 1173358 A1 HK1173358 A1 HK 1173358A1
Authority
HK
Hong Kong
Prior art keywords
fviii
derived peptides
derived
peptides
peptides fviii
Prior art date
Application number
HK12111247.4A
Other languages
English (en)
Inventor
David Wraith
Original Assignee
艾匹托普國際股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40834163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1173358(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 艾匹托普國際股份有限公司 filed Critical 艾匹托普國際股份有限公司
Publication of HK1173358A1 publication Critical patent/HK1173358A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK12111247.4A 2009-05-18 2012-11-07 衍生肽 HK1173358A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0908515.0A GB0908515D0 (en) 2009-05-18 2009-05-18 Peptide
PCT/GB2010/000997 WO2010133834A2 (en) 2009-05-18 2010-05-17 Peptide

Publications (1)

Publication Number Publication Date
HK1173358A1 true HK1173358A1 (zh) 2013-05-16

Family

ID=40834163

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111247.4A HK1173358A1 (zh) 2009-05-18 2012-11-07 衍生肽

Country Status (31)

Country Link
US (1) US8703705B2 (zh)
EP (2) EP2465523B1 (zh)
JP (1) JP5784009B2 (zh)
KR (1) KR101673889B1 (zh)
CN (1) CN102458445B (zh)
AU (1) AU2010250957B2 (zh)
BR (1) BRPI1012845A2 (zh)
CA (1) CA2762020C (zh)
CL (1) CL2011002893A1 (zh)
CO (1) CO6460780A2 (zh)
CY (1) CY1115832T1 (zh)
DK (1) DK2465523T3 (zh)
EA (1) EA027229B1 (zh)
EC (1) ECSP11011540A (zh)
ES (1) ES2525448T3 (zh)
GB (1) GB0908515D0 (zh)
HK (1) HK1173358A1 (zh)
HR (1) HRP20141182T1 (zh)
IL (1) IL216199A (zh)
MX (1) MX2011012270A (zh)
MY (1) MY168207A (zh)
NZ (2) NZ613713A (zh)
PL (1) PL2465523T3 (zh)
PT (1) PT2465523E (zh)
RS (1) RS53671B1 (zh)
SG (2) SG190573A1 (zh)
SI (1) SI2465523T1 (zh)
SM (1) SMT201400186B (zh)
UA (1) UA110921C2 (zh)
WO (1) WO2010133834A2 (zh)
ZA (1) ZA201108446B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2506868T (lt) 2009-12-06 2018-02-26 Bioverativ Therapeutics Inc. Faktoriaus viii-fc chimeriniai ir hibridiniai polipeptidai ir jų panaudojimo būdai
NZ708812A (en) * 2012-11-12 2019-03-29 Apitope Int Nv Fviii peptides, compositions and uses of same
GB201314052D0 (en) * 2013-08-06 2013-09-18 Apitope Int Nv Peptides
PE20231949A1 (es) 2015-10-30 2023-12-05 Spark Therapeutics Inc VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1311542B1 (en) 2000-08-21 2008-07-16 Apitope Technology (Bristol) Limited Tolerogenic peptides
WO2002060917A2 (en) * 2000-12-01 2002-08-08 Regents Of The University Of Minnesota Method to treat hemophilia
AU2002312660A1 (en) * 2001-05-31 2002-12-16 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
WO2002096454A1 (en) 2001-05-31 2002-12-05 D. Collen Research Foundation Vzw Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
CN1646564A (zh) 2002-04-18 2005-07-27 默克专利有限公司 修饰的因子ⅷ
GB0723712D0 (en) * 2007-12-04 2008-01-16 Apitope Technology Bristol Ltd Peptides
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII

Also Published As

Publication number Publication date
NZ596300A (en) 2013-08-30
HRP20141182T1 (hr) 2015-02-13
RS53671B1 (en) 2015-04-30
ES2525448T3 (es) 2014-12-23
PL2465523T3 (pl) 2015-03-31
UA110921C2 (uk) 2016-03-10
SI2465523T1 (sl) 2015-02-27
CN102458445B (zh) 2014-06-11
EA201171430A1 (ru) 2012-05-30
US20120121625A1 (en) 2012-05-17
EA027229B1 (ru) 2017-07-31
JP2012527440A (ja) 2012-11-08
CA2762020C (en) 2018-08-28
SG176138A1 (en) 2011-12-29
DK2465523T3 (en) 2014-12-15
IL216199A (en) 2015-11-30
KR20120023023A (ko) 2012-03-12
SG190573A1 (en) 2013-06-28
CA2762020A1 (en) 2010-11-25
US8703705B2 (en) 2014-04-22
CO6460780A2 (es) 2012-06-15
JP5784009B2 (ja) 2015-09-24
EP2465523A1 (en) 2012-06-20
ZA201108446B (en) 2013-01-30
IL216199A0 (en) 2012-01-31
AU2010250957B2 (en) 2015-01-15
KR101673889B1 (ko) 2016-11-08
SMT201400186B (it) 2015-01-15
ECSP11011540A (es) 2012-01-31
GB0908515D0 (en) 2009-06-24
NZ613713A (en) 2014-10-31
WO2010133834A3 (en) 2011-02-24
EP2465523B1 (en) 2014-10-01
EP2432494A2 (en) 2012-03-28
CN102458445A (zh) 2012-05-16
MY168207A (en) 2018-10-15
AU2010250957A1 (en) 2011-12-01
PT2465523E (pt) 2014-12-09
BRPI1012845A2 (pt) 2016-10-11
MX2011012270A (es) 2011-12-12
WO2010133834A2 (en) 2010-11-25
CY1115832T1 (el) 2017-01-25
CL2011002893A1 (es) 2012-08-17

Similar Documents

Publication Publication Date Title
HK1218558A1 (zh) 蛋白
GB0913775D0 (en) Multispecific peptides
GB201012651D0 (en) Peptides
EP2437770A4 (en) ANTIMICROBIAL PEPTIDES
PL2496596T3 (pl) Peptydy terapeutyczne
EP2480578A4 (en) MODIFICATION OF POLYPEPTIDE
HK1220701A1 (zh) 胰島素樣肽
EP2513137A4 (en) PEPTIDES DERIVED FROM SAPOSINE-A AND USES THEREOF
GB0920981D0 (en) Peptides
IL214257A0 (en) Peptides for vaccine
GB0921995D0 (en) Antimicrobial peptides
HK1171672A1 (zh) 新蛋白
EP2627674A4 (en) EGFR BASED PEPTIDES
HK1173358A1 (zh) 衍生肽
EP2435468A4 (en) PEPTIDE OF FIBROMODULIN
ZA201203722B (en) Peptide
GB0921691D0 (en) Sophorolpid transporter protien
GB0917685D0 (en) Antigenic polypeptide
EP2370100A4 (en) PEPTIDE AGENTS
EP2439209A4 (en) PEPTIDES BASED ON ENDOKININS C / D
GB0920987D0 (en) Peptides
GB0817978D0 (en) Peptides
GB0911790D0 (en) Peptides
IL214496A0 (en) Short b-defensin-derived peptides
GB0909494D0 (en) Neuroprotective peptide

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190516